| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/12/2007 | US20070160666 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; free of ascorbic acid and pregelatinized starch; for treatment of atheroslerosis; stability |
| 07/12/2007 | US20070160657 Targeting and intestinal-absorption controlled liposome having sugar chain and therapeutic drug for cancer and diagnostic drug containing the liposome |
| 07/12/2007 | US20070160622 Method for assembling a polymer-biologic delivery composition |
| 07/12/2007 | US20070160620 Immune responses using compositions containing stress proteins |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160589 Probiotic food, process for its preparation and dietary regimen |
| 07/12/2007 | US20070160573 Peptide conjugated anti-cancer prodrugs |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160568 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160556 Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | CA2841386A1 Extended release of neuregulin for improved cardiac function |
| 07/12/2007 | CA2635594A1 Gastric release pulse system for drug delivery |
| 07/12/2007 | CA2634993A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | CA2634989A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/12/2007 | CA2633167A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 07/11/2007 | EP1806377A1 Temperature-responsive depsipeptide polymer |
| 07/11/2007 | EP1806367A2 Polymers containing polysaccharides such as alginates or modified alginates |
| 07/11/2007 | EP1806365A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 07/11/2007 | EP1806361A1 Erythropoietin liquid formulation |
| 07/11/2007 | EP1806354A2 Amphoteric sterols and their use |
| 07/11/2007 | EP1806152A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806151A1 Drug for external use and adhesive patch |
| 07/11/2007 | EP1806150A1 Teicoplanin composition |
| 07/11/2007 | EP1806149A1 Solid medicinal preparation improved in solubility and stability and process for producing the same |
| 07/11/2007 | EP1806129A1 Composition containing fine particles and process for producing the same |
| 07/11/2007 | EP1806123A2 Storage-stable compositions of glycerol monoalkyl ethers |
| 07/11/2007 | EP1805246A1 End-capped poly(ester amide) copolymers |
| 07/11/2007 | EP1805217A2 Method for the preparation of oxime, thiazolidine, dithiane, dithiolane or hydrazone linked analogues of growth hormone |
| 07/11/2007 | EP1805139A2 Therapeutic and delivery methods of prostaglandin ep4 agonists |
| 07/11/2007 | EP1804880A1 Medical devices and methods of preparation and use |
| 07/11/2007 | EP1804838A2 Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs |
| 07/11/2007 | EP1804814A2 Multi-purpose bio-material composition |
| 07/11/2007 | EP1804813A2 Formulations and methods for treatment of inflammatory diseases |
| 07/11/2007 | EP1804787A2 Flavonoid composition for treating oral diseases |
| 07/11/2007 | EP1804765A2 Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| 07/11/2007 | EP1741425A4 Novel antiviral pharmaceutical composition |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1458398A4 Antibiotic formulation and a method of making this formulation |
| 07/11/2007 | EP1383816B1 Film-forming composition for topical use and use thereof for delivering active agents |
| 07/11/2007 | EP1345549A4 Dispensing device |
| 07/11/2007 | EP1301179B1 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 07/11/2007 | EP1206284B1 Method for delivery of therapeutic agents using a solution of dextrin |
| 07/11/2007 | EP1135682B1 Nanoparticles with polymer shells |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |
| 07/11/2007 | EP0927214B1 Polymerizable biodegradable polymers including carbonate or dioxanone linkages |
| 07/11/2007 | CN1997666A Polyethylene glycol modified interferon compositions and methods of use thereof |
| 07/11/2007 | CN1997661A Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
| 07/11/2007 | CN1997403A Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 07/11/2007 | CN1997402A Cytotoxic compounds and conjugates |
| 07/11/2007 | CN1997401A Preparation of macromolecular conjugates by four-component condensation reaction |
| 07/11/2007 | CN1997400A Conjugated psychotropic drugs and uses thereof |
| 07/11/2007 | CN1997399A Polymer conjugate releasable under mild thiolytic conditions |
| 07/11/2007 | CN1997398A Passive targeting of cytotoxic agents |
| 07/11/2007 | CN1997397A Calicheamicin conjugates |
| 07/11/2007 | CN1997380A Composition for antianxiety drug containing vegetable essence ingredient as active ingredient, antianxiety drug employing the composition, and processes for producing these |
| 07/11/2007 | CN1997356A Sustained release formulations |
| 07/11/2007 | CN1997352A Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 07/11/2007 | CN1995094A Multiple-arm polyethylene glycol with functional group at long chain end, its preparation method and uses |
| 07/11/2007 | CN1994469A Biodegradable magnetic nanoparticle, preparation method and application thereof |
| 07/11/2007 | CN1994468A Unfavorable taste-masking drug granule, chewable formulation and preparation process thereof |
| 07/11/2007 | CN1994467A Drug flavor masking method |
| 07/11/2007 | CN1994425A Soft capsule of 'Sheng Mai' and preparation method thereof |
| 07/11/2007 | CN1994424A Chinese medicinal tablet and preparation method thereof |
| 07/11/2007 | CN1994389A Production method of soft capsule for treating pelvic inflammation |
| 07/11/2007 | CN1994385A Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 07/11/2007 | CN1994373A Formulation with basil, ginkgo leaf and notoginseng, preparation process and quality control method |
| 07/11/2007 | CN1994367A Marine medicine for treating hypertension, preparation process and dispersible tablet thereof |
| 07/11/2007 | CN1994355A Gadol effervescence tablet |
| 07/11/2007 | CN1994307A Compound transdermal drug-delivery preparation for preventing intoxication of organophosphorus ester compound |
| 07/11/2007 | CN1994306A Sustained-release preparation containing captopril and hydrochlorothiazide and preparation process thereof |
| 07/11/2007 | CN1994304A Compound orally disintegrating tablet containing loratadine and ambroxol and preparation process thereof |
| 07/11/2007 | CN1994303A Sustained release preparation containing pseudoephedrine and desloratadine and preparation process thereof |
| 07/11/2007 | CN1994297A Sustained-release preparation containing metformin hydrochloride and glimepiride and preparation process thereof |
| 07/11/2007 | CN1994296A Pharmaceutical composition containing simvastatin |
| 07/11/2007 | CN1994291A Target-oriented sustained-release microsphere containing paclitaxel and albumin and preparation process thereof |
| 07/11/2007 | CN1994290A Transdermal plaster of rivastigmine and preparation process thereof |
| 07/11/2007 | CN1994288A Red sage root salvianolic acid A tablet for treating cardiovascular disease and preparation process thereof |
| 07/11/2007 | CN1994284A Preparation process of nano drug-loaded biological micro-capsule |
| 07/11/2007 | CN1994283A Sustained-release preparation of nicorandil |
| 07/11/2007 | CN1994282A Sustained-release preparation of mexiletine |
| 07/11/2007 | CN1994281A Sustained-release preparation of midecamycin |
| 07/11/2007 | CN1994280A Sustained-release micro-pellet of trimetazidine and preparation process thereof |
| 07/11/2007 | CN1325650C Delivery system for porcine somatotropin |
| 07/11/2007 | CN1325454C Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 07/11/2007 | CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 07/11/2007 | CN1325117C 联合疫苗组合物 Combined vaccine composition |
| 07/11/2007 | CN1325116C Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer |
| 07/11/2007 | CN1325056C Chloasma amelioration composition and dullness amelioration composition |
| 07/11/2007 | CN1325054C Cyclic dextrin inclusion compound of mintpress hydrochloride and its preparing method |
| 07/11/2007 | CN1325049C Composition containing epigallocatechin gallate |
| 07/11/2007 | CN1324978C Chewing gum with filling containing calcium |
| 07/10/2007 | US7241845 controlled release compositions for veterinary medicines; hydrogel comprising hydrophilic polyethylene oxide segments and hydrophobic segments containing urethane groups and urea groups; organic solvent-soluble |
| 07/10/2007 | US7241813 Comprises ethylene oxide-propylene oxide copolymers; may be combined with demineralized bone particles to form tissue repair composition; bone morphogenic proteins |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241742 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferative disorders |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |